What were Advanced Enzyme Technologies Ltd's latest quarterly results?
Advanced Enzyme Technologies Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +10.3%
- Revenue Growth YoY: +1.8%
- Operating Margin: 29.0%
Advanced Enzyme Technologies Ltd (Seeds/Tissue Culture/Bio Technology) — fundamental analysis, earnings data, and key metrics. PE: 20.7. ROE: 9.5%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Advanced Enzyme Technologies Ltd's latest quarterly results (Dec 2025) show
Advanced Enzyme Technologies Ltd's current PE ratio is 20.7x.
Advanced Enzyme Technologies Ltd's price-to-book ratio is 2.0x.
Advanced Enzyme Technologies Ltd's fundamental strength based on key financial ratios
Advanced Enzyme Technologies Ltd has a debt-to-equity ratio of N/A.
Advanced Enzyme Technologies Ltd's return ratios over recent years
Advanced Enzyme Technologies Ltd's operating cash flow is positive (FY2025).
Advanced Enzyme Technologies Ltd's current dividend yield is 1.96%.
Advanced Enzyme Technologies Ltd's shareholding pattern (Dec 2025)
Advanced Enzyme Technologies Ltd's promoter holding has decreased recently.
Advanced Enzyme Technologies Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Advanced Enzyme Technologies Ltd may be worth studying
Advanced Enzyme Technologies Ltd investment thesis summary:
Advanced Enzyme Technologies Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.